Fluciclatide F-18

N/A

Report date: 2025/11/20 11:38:31

NME

Base Information

Drug NameFluciclatide F-18

Drug Alias Name18F-FluciclatideAH111585-18F[18F]AH-111585

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5]

Mechanisms of ActionPositron-emission tomography enhancers

TargetsNot applicable

Therapy Area/IndicationsKidney Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGe Healthcare

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGe Healthcare

Active IndicationsN/A

Inactive IndicationsKidney Neoplasms

Other Information

ATC CodeN/A